Vaxart VXRT will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Vaxart to report an earnings per share (EPS) of $-0.10.
The announcement from Vaxart is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
During the last quarter, the company reported an EPS missed by $0.06, leading to a 7.95% drop in the share price on the subsequent day.
Here's a look at Vaxart's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.03 | -0.14 | -0.14 | -0.18 |
| EPS Actual | -0.09 | -0.14 | -0.12 | -0.11 |
| Price Change % | -8.0% | 5.0% | -2.0% | 5.0% |
Market Performance of Vaxart's Stock
Shares of Vaxart were trading at $0.6938 as of November 11. Over the last 52-week period, shares are down 17.65%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Vaxart visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
